Medicines Use and Safety Team – Annual Report 2017-18
13th August 2018Highlights for 2017-18 include: Medicines and the National Inpatient Survey Polypharmacy and deprescribing Consultant Pharmacist toolkit Patient Group Directions Q & As
Our expert advice and services can help you make informed decisions and put your patients’ needs first to bring them better health
About SPSLearn more about the Regional Medicines Optimisation Committees for England, view recommendations and resources, and raise a topic
NetworksView our repository of good practice examples that help deliver the WHO Medication Without Harm Global Patient Safety challenge
WHO Good Practice RepositoryHighlights for 2017-18 include: Medicines and the National Inpatient Survey Polypharmacy and deprescribing Consultant Pharmacist toolkit Patient Group Directions Q & As
PGD documentation includes master authorised (signed) copies of PGDs, lists of authorised practitioners and patient supply/administration records, including electronic records/agreements. The same rules apply to…
PGD documentation includes master authorised (signed) copies of PGDs, lists of authorised practitioners and patient supply/administration records, including electronic records/agreements. The same rules apply to…
This article considers the risk of interactions between NOACs and antidepressants. Non-vitamin K antagonist oral anticoagulants (NOACs) appear to have fewer clinically significant drug interactions…
Here is a guide to searching the SPS Website for information on medicines.
We are pleased to announce that we have formed the Pharmacy Fellows Network of aspiring leaders who are proactive, innovative and effective. This is an…